Chemotherapy Plus Anti–PD-1 Agents as Adjuvant Therapy for High-Risk Oral Mucosal Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Cancer Research and Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Chemotherapy in combination with anti-PD-1 agents as adjuvant therapy for high-risk oral mucosal melanoma
J. Cancer Res. Clin. Oncol. 2022 Sep 11;[EPub Ahead of Print], Y Wu, D Wei, G Ren, W GuoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.